Hormone therapy was associated with more frequent, longer migraines in postmenopausal women, but not with greater severity or analgesic use.
News|Videos|May 21, 2025
Expert discussions from the 2025 ACOG meeting
Author(s)Celeste Krewson, Assistant Editor
Watch some highlights from our discussions with experts presenting at the 2025 ACOG meeting.
Advertisement
Advertisement
Thank you for visiting the Contemporary OB/GYN website, and for following along with our coverage of the 2025 American College of Obstetrics & Gynecology (ACOG) Annual Clinical & Scientific Meeting held in Minneapolis, Minnesota.
Related to this article
Menopausal brain fog is common, and hormone therapy has neutral cognitive effects, according to Pauline M. Maki, PhD.
Stephanie S. Faubion, MD, on choosing between fezolinetant and elinzanetant, liver monitoring, follow-up, and open questions in menopause care.
NK receptor antagonists significantly improved sleep disturbance in menopausal women at 4, 12, and 24 weeks in a meta-analysis of RCTs.
Perimenopausal women who were more physically active had significantly lower symptom burden across all domains, a study of 1808 Flo app users found.
JoAnn V. Pinkerton, MD, MSCP, reviews 4 pooled elinzanetant analyses from OASIS presented at The Menopause Society Annual Meeting 2026, spanning late perimenopause, sleep, VMS reduction, and safety.
Distress, not low libido alone, defines HSDD, which requires a biopsychosocial evaluation, according to Holly N. Thomas, MD, MS.
Perimenopausal women over-reported total sleep time by a mean of 35.3 minutes and under-reported wake time compared with Fitbit data.
Advertisement
Advertisement